Latest California Healthline Stories
Everyone Says We Must Control Exorbitant Drug Prices. So, Why Don’t We?
Any momentum to address prescription drug costs has been lost amid rancorous debates over replacing Obamacare and stalled by roadblocks erected via lobbying and industry cash.
High On Drugs? Anthem Cites Soaring Drug Costs To Justify 35% Rate Hike in California
The company’s drug spending prediction, far above other insurers in the individual market, has experts scratching their heads. Anthem cites market volatility.
State Lawmakers Tackle Public Smoking And Lead Poisoning, But Punt On Single-Payer
California lawmakers adopted a drug price transparency bill and several other key health care measures as their legislative session ended last week, but they pushed off decisions on some big-name proposals such as single-payer health care.
California Drug Price Bill Sweeping In Scope, Lacking In Muscle
The proposal, which is headed to the desk of Gov. Jerry Brown, would impose new reporting requirements on drugmakers and health plans but wouldn’t have the power to bring down prices directly.
FDA Guards Against Abuse Of ‘Orphan Drug’ Program
Following a KHN and NPR investigation, the Food and Drug Administration has moved to speed up approvals of “orphan drugs” while closing a loophole that allowed drugmakers to skip pediatric testing.
Facebook Live: The Prescription Drug Pricing Pipeline
In this Facebook Live, KHN’s Julie Appleby talks with Stephanie Stapleton and answers readers’ questions about the prescription drug pricing pipeline and the industry stakeholders who have a role in what you pay.
Nueva droga contra la leucemia ofrece esperanza, pero a un costo millonario
El tratamiento con una nueva droga del laboratorio Novartis para casos en los que ha fracasado la quimioterapia o el trasplante de médula costaría $649,000.
‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
Podcast: ‘What The Health?’ Counties Coping With Scant Insurance Coverage
In this episode of “What the Health?” Mary Agnes Carey of Kaiser Health News, Sarah Karlin-Smith of Politico, Margot Sanger-Katz of The New York Times and Julie Appleby of Kaiser Health News discuss the problems some consumers will face with a lack of exchange-based insurance coverage in their regions. They also talk about the state of play on Capitol Hill and in the states concerning initiatives to lower prescription drug costs.
Hospitals Slashed Use Of Two Heart Drugs After Huge Price Hikes
Hospital use of two popular heart medicines, nitroprusside and isoproterenol, dramatically dropped after the prices for both soared.